SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .
08 diciembre 2008
Velcade . Blood-Cancer Drug Hits $1 Billion .
Year-to-date sales of blood-cancer drug Velcade hit $1 billion in November, indicating the medicine's sales grew more than 25% in a year that saw broadened approval from the Food and Drug Administration ...
‹
›
Inicio
Ver versión web